{"id":"W2416393073","doi":"","title":"Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design.","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Bicalutamide; Dutasteride; Medicine; Antiandrogen; Dihydrotestosterone; Prostate cancer; Urology; Testosterone (patch); Internal medicine; Endocrinology; Androgen deprivation therapy; Oncology; Androgen receptor; Androgen; Cancer; Hormone","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007164535,0.00230573,0.00287041,0.0004236056,0.000719914,0.001304318,0.001369911,0.002360035,0.006058272],"category_scores_gemma":[0.003788304,0.000890889,0.002114517,0.0008756813,0.001718166,0.0007678622,0.0006189287,0.002682718,0.001282081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001044312,"about_ca_system_score_gemma":0.00449106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00122896,"about_ca_topic_score_gemma":0.002613486,"domain_scores_codex":[0.9955343,0.003099387,0.0002287693,0.0004008706,0.0003772761,0.00035936],"domain_scores_gemma":[0.9980124,0.0005252361,0.0004451894,0.0001551109,0.0002165139,0.0006455057],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.9441593,0.01090381,0.005266197,0.002917585,0.002029356,0.0002272635,0.0001959366,0.0005287237,0.005343684,0.0008607212,0.002004148,0.02556329],"study_design_scores_gemma":[0.8347977,0.1517837,0.004403981,0.0001630591,0.001294636,0.000126831,0.00005533642,0.0003833519,0.0009139771,0.0005345981,0.005509598,0.00003332854],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.6944045,0.0230648,0.004254049,0.005275832,0.002002339,0.2516944,0.006769066,0.0002092595,0.01232577],"genre_scores_gemma":[0.7841263,0.007150146,0.008053982,0.005676504,0.001587865,0.1820735,0.00257337,0.00005458475,0.00870369],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.007164535,"threshold_uncertainty_score":0.03789014,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02914106314790599,"score_gpt":0.2772291722623604,"score_spread":0.2480881091144544,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}